OCT 21, 2026 · JOURNAL ARTICLE
EXO1 inhibition selectively kills replication repair-deficient cancer cells.
Nar Cancer
Deficiencies in DNA repair pathways create context-specific vulnerabilities that may be exploited therapeutically. Recent studies have established EXO1 as a druggable nuclease, but